Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-07T06:27:52.487Z Has data issue: false hasContentIssue false

3 - Pathology of pulmonary hypertension

Published online by Cambridge University Press:  06 January 2010

Nicholas R. Banner
Affiliation:
Royal Brompton and Harefield NHS Trust, Imperial College of Science, Technology and Medicine, London
Julia M. Polak
Affiliation:
Imperial College of Science, Technology and Medicine, London
Magdi H. Yacoub
Affiliation:
University of London
Get access

Summary

Introduction

The pulmonary circulation receives the entire cardiac output and its vessels are uniquely structured to provide a low resistance system to accommodate the high flow. Thus the vessels are thin walled, comparatively wide, and acutely sensitive to raised pressure. The pulmonary arterial pressure for a normal resting adult at sea level is 14 ± 3 mmHg (1 mmHg ≈ 133.3 Pa) (mean ± standard error of the mean) and so pulmonary hypertension is defined as a level that would be expected to occur in fewer than 1% of a normal population; 25 mmHg or above at rest [1, 2]. This allows a clinical diagnosis to be made. At present, in line with the National Institutes of Health (NIH) Registry, exclusion of possible causative conditions, such as cardiac, respiratory, thromboembolic or connective tissue diseases, allows a diagnosis of idiopathic (or primary) rather than secondary pulmonary hypertension. For secondary disease, the predisposing condition is usually evident and patients can be monitored for possible hypertensive changes. The idiopathic form is insidious and, when it does finally present clinically, it is with nonspecific symptoms of dyspnoea and fatigue, so diagnosis is delayed, on average by two years [2]. The principal pathological feature of chronic pulmonary hypertension is pulmonary vascular remodelling, where both the cellular and extracellular components of the arteries undergo dramatic reorganization.

Our knowledge of the pathogenesis of pulmonary hypertension is limited and, consequently, despite major advances in recent years, pharmacological therapy is not always successful. For primary disease in particular, there is no real cure and lung or heart–lung transplantation is often the only option for survival [3].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×